NL-OMON34571已完成不适用
Pharmacokinetics and metabolism of [14C]BMS-820836 in healthy male subjects - [14C] BMS-820836 ADME study
Bristol-Myers Squibb0 个研究点目标入组 6 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy male subjects, up to moderate smoking
- •Age: 18-45 years
- •BMI: 18.0-30.0 kg/m2
排除标准
- •Suffering from: hepatitis B, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study or in case of donating more than 1 liter of blood in the 10 months prior the start of this study.
研究者
相似试验
已完成
不适用
Pharmacokinetics and metabolism of [14C] BMS-986195 in healthy male subjects10023213Rheumatoid arthritisNL-OMON44627Bristol-Myers Squibb Research and Development9
已完成
1 期
Absorption, Distribution, Metabolism and Excretion (ADME) Study of BMS-986020Immunosuppression For DiseaseNCT02068053Bristol-Myers Squibb6
已完成
1 期
Study of the Absorption, Metabolism, and Route of Elimination of a Novel Class of Anti-HIV 1 Drugs (BMS-955176) in Humans.HIV InfectionsNCT02206711ViiV Healthcare21
已完成
1 期
Pharmacokinetics and Metabolism Study in Healthy Male ParticipantsCancerNCT03247283Bristol-Myers Squibb9
已完成
1 期
Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male ParticipantsPsoriasisNCT03004768Bristol-Myers Squibb6